BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 28
• 29
• 30
• 31

• Mindray Medical Announces Its Recent Filing of Annual Report on Form 20-F With the U.S. Securities and Exchange Commission

  May 21, 2013

   · 

  1 min read
• Drug Development

  Sunovion Pharmaceuticals Inc. Presents Data Showing 12 Months of Latuda® (lurasidone HCl) Treatment Resulted in Higher Remission Rates in Adult Patients With Schizophrenia Compared to Seroquel XR® (quetiapine XR)

  May 21, 2013

   · 

  1 min read
• Avion Pharmaceuticals, Launches Prenate Chewable™, the Newest Addition to the Prenate® Prenatal Vitamin Family

  May 21, 2013

   · 

  1 min read
• Drug Development

  TRANSGENE Announces Completion of Enrollment in TRAVERSE, a Phase 2b Clinical Trial of Pexa-Vec for the Treatment of Liver Cancer

  May 21, 2013

   · 

  1 min read
• Drug Development

  AstraZeneca PLC Release: Results From Phase III Studies of Naloxegol for Treatment of Opioid-Induced Constipation Presented at Digestive Disease Week 2013

  May 21, 2013

   · 

  1 min read
• Genetown

  Boston Scientific Corporation Long Term Data Demonstrate Bronchial Thermoplasty Treatment Benefits Persist Out to Five Years in Patients With Severe Asthma

  May 21, 2013

   · 

  7 min read
• Business

  ALung Technologies to Pursue SFDA Approval of Hemolung RAS in China

  May 21, 2013

   · 

  1 min read
• Drug Development

  Addex Therapeutics Validates Potential Efficacy Biomarker for Phase 1 Trial of Its GABA-B Positive Allosteric Modulator, ADX71441

  May 21, 2013

   · 

  7 min read
• BioCapital

  Biotechnology Industry Organization (BIO) Issues Call for Paper and Panel Submissions for 2013 Pacific Rim Summit on Industrial Biotech and Bioenergy

  May 21, 2013

   · 

  1 min read
• Policy

  Biogen Idec, Inc. (Massachusetts) Submits Application to FDA for Approval of PLEGRIDY™ (Peginterferon Beta-1a) in Multiple Sclerosis

  May 21, 2013

   · 

  1 min read